(Q77214245)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10189148%20AND%20SRC:MED&resulttype=core&format=json

3 December 2019

title

Induction failure in acute lymphoblastic leukemia of childhood (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10189148%20AND%20SRC:MED&resulttype=core&format=json

3 December 2019

main subject

lymphoblastic leukemia

1 reference

L B Silverman

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10189148%20AND%20SRC:MED&resulttype=core&format=json

3 December 2019

R D Gelber

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10189148%20AND%20SRC:MED&resulttype=core&format=json

3 December 2019

M L Young

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10189148%20AND%20SRC:MED&resulttype=core&format=json

3 December 2019

V K Dalton

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10189148%20AND%20SRC:MED&resulttype=core&format=json

3 December 2019

R D Barr

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10189148%20AND%20SRC:MED&resulttype=core&format=json

3 December 2019

S E Sallan

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10189148%20AND%20SRC:MED&resulttype=core&format=json

3 December 2019

publication date

1 March 1999

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10189148%20AND%20SRC:MED&resulttype=core&format=json

3 December 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10189148%20AND%20SRC:MED&resulttype=core&format=json

3 December 2019

volume

85

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10189148%20AND%20SRC:MED&resulttype=core&format=json

3 December 2019

issue

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10189148%20AND%20SRC:MED&resulttype=core&format=json

3 December 2019

page(s)

1395-1404

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10189148%20AND%20SRC:MED&resulttype=core&format=json

Treatment of childhood acute lymphoblastic leukemia: results of Dana-Farber Cancer Institute/Children's Hospital Acute Lymphoblastic Leukemia Consortium Protocol 85-01.

3 December 2019

cites work

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819990315%2985%3A6%3C1395%3A%3AAID-CNCR25%3E3.0.CO%3B2-2

Improved outcome in childhood acute lymphoblastic leukaemia with reinforced early treatment and rotational combination chemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819990315%2985%3A6%3C1395%3A%3AAID-CNCR25%3E3.0.CO%3B2-2

Comparison of two schedules of intermediate-dose methotrexate and cytarabine consolidation therapy for childhood B-precursor cell acute lymphoblastic leukemia: a Pediatric Oncology Group study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819990315%2985%3A6%3C1395%3A%3AAID-CNCR25%3E3.0.CO%3B2-2

Intensification of treatment and survival in all children with lymphoblastic leukaemia: results of UK Medical Research Council trial UKALL X. Medical Research Council Working Party on Childhood Leukaemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819990315%2985%3A6%3C1395%3A%3AAID-CNCR25%3E3.0.CO%3B2-2

Extended intrathecal methotrexate may replace cranial irradiation for prevention of CNS relapse in children with intermediate-risk acute lymphoblastic leukemia treated with Berlin-Frankfurt-Münster-based intensive chemotherapy. The Associazione Ital

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819990315%2985%3A6%3C1395%3A%3AAID-CNCR25%3E3.0.CO%3B2-2

Improved outcome with delayed intensification for children with acute lymphoblastic leukemia and intermediate presenting features: a Childrens Cancer Group phase III trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819990315%2985%3A6%3C1395%3A%3AAID-CNCR25%3E3.0.CO%3B2-2

Comparative pharmacokinetic studies of three asparaginase preparations

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819990315%2985%3A6%3C1395%3A%3AAID-CNCR25%3E3.0.CO%3B2-2

Nonparametric Estimation from Incomplete Observations

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819990315%2985%3A6%3C1395%3A%3AAID-CNCR25%3E3.0.CO%3B2-2

Teniposide (VM-26) and continuous infusion cytosine arabinoside for initial induction failure in childhood acute lymphoblastic leukemia. A Pediatric Oncology Group pilot study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819990315%2985%3A6%3C1395%3A%3AAID-CNCR25%3E3.0.CO%3B2-2

Treatment of primary refractory and relapsed acute lymphoblastic leukaemia in children and adults: the GIMEMA/AIEOP experience. Gruppo Italiano Malattie Ematologiche Maligne dell'Adulto. Associazione Italiana Ematologìa ed Ocologia Pediatrica

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819990315%2985%3A6%3C1395%3A%3AAID-CNCR25%3E3.0.CO%3B2-2

Allogeneic bone marrow transplantation for children with acute lymphoblastic leukemia in first remission: a cooperative study of the Groupe d'Etude de la Greffe de Moelle Osseuse.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819990315%2985%3A6%3C1395%3A%3AAID-CNCR25%3E3.0.CO%3B2-2

Early response to induction therapy as a predictor of disease-free survival and late recurrence of childhood acute lymphoblastic leukemia: a report from the Childrens Cancer Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819990315%2985%3A6%3C1395%3A%3AAID-CNCR25%3E3.0.CO%3B2-2

Day 7 marrow response and outcome for children with acute lymphoblastic leukemia and unfavorable presenting features

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819990315%2985%3A6%3C1395%3A%3AAID-CNCR25%3E3.0.CO%3B2-2

Augmented post-induction therapy for children with high-risk acute lymphoblastic leukemia and a slow response to initial therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819990315%2985%3A6%3C1395%3A%3AAID-CNCR25%3E3.0.CO%3B2-2

Outcome prediction in childhood acute lymphoblastic leukaemia by molecular quantification of residual disease at the end of induction

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819990315%2985%3A6%3C1395%3A%3AAID-CNCR25%3E3.0.CO%3B2-2

Immunological detection of minimal residual disease in children with acute lymphoblastic leukaemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819990315%2985%3A6%3C1395%3A%3AAID-CNCR25%3E3.0.CO%3B2-2

Clinical significance of minimal residual disease in childhood acute lymphoblastic leukemia. European Organization for Research and Treatment of Cancer--Childhood Leukemia Cooperative Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819990315%2985%3A6%3C1395%3A%3AAID-CNCR25%3E3.0.CO%3B2-2

10.1002/(SICI)1097-0142(19990315)85:6<1395::AID-CNCR25>3.0.CO;2-2

21 January 2018

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10189148%20AND%20SRC:MED&resulttype=core&format=json

3 December 2019

1 reference